Depentylation of [3H-pentyl]methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome P450 isoforms

Sheng C. Chen, Xiaojie Wang, Guoping Xu, Lin Zhou, Jonathan L. Vennerstrom, Frank Gonzalez, Harry V. Gelboin, Sidney S. Mirvish

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Methyl-n-amylnitrosamine (MNAN) induces esophageal cancer in rats, probably involving activation by cytochromes P450. We studied the metabolic depentylation of MNAN. [3H-4,5-pentyl]-MNAN and [3H-2,3-pentyl]. MNAN were synthesized, purified, and incubated with rat esophageal microsomes (REM) or rat liver microsomes (RLM) to give [3H]pentaldehyde (depentylation), an indicator of MNAN activation. [3H]Pentaldehyde was determined by high- performance liquid chromatography of its 2,4-dinitrophenylhydrazone. Adding 5 mM semicarbazide to incubations increased the observed depentylation (except that due to CYP2E1) by >60%. MNAN depentylation by REM and uninduced and induced RLM showed K(m) values of 64, 610, and 170-330 μM, respectively (V(max): 20, 220, and 160-1270 pmol/mg protein/min, respectively). The depentylation of 100 μM MNAN by REM was inhibited 98% by CO and 65% by coumarin preincubated for 15 min with REM (K(i), 120 μM) but was unaffected by antibodies inhibitory to various P450s. MNAN inhibited coumarin 7- hydroxylation by RLM and CYP2A6 (K(i), 3000 and 320 μM, respectively). REM showed slight coumarin 7-hydroxylase activity. MNAN depentylation by RLM was 41% inhibited by an antibody to CYP2C11. K(m) for rat CYP2E1, human CYP2E1, and human CYP2A6 was 210, 115, and 17 μM, respectively (V(max:) 900, 570, and 120 pmol/nmol P450/min, respectively). We conclude that MNAN activation by REM is probably due to a P450 related to CYP2A3, a rodent nasal P450.

Original languageEnglish (US)
Pages (from-to)91-98
Number of pages8
JournalCancer Research
Volume59
Issue number1
StatePublished - Jan 1 1999

Fingerprint

N-amyl-N-methylnitrosamine
Liver Microsomes
Cytochrome P-450 Enzyme System
Protein Isoforms
Microsomes
Cytochrome P-450 CYP2E1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Depentylation of [3H-pentyl]methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome P450 isoforms. / Chen, Sheng C.; Wang, Xiaojie; Xu, Guoping; Zhou, Lin; Vennerstrom, Jonathan L.; Gonzalez, Frank; Gelboin, Harry V.; Mirvish, Sidney S.

In: Cancer Research, Vol. 59, No. 1, 01.01.1999, p. 91-98.

Research output: Contribution to journalArticle

Chen, Sheng C. ; Wang, Xiaojie ; Xu, Guoping ; Zhou, Lin ; Vennerstrom, Jonathan L. ; Gonzalez, Frank ; Gelboin, Harry V. ; Mirvish, Sidney S. / Depentylation of [3H-pentyl]methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome P450 isoforms. In: Cancer Research. 1999 ; Vol. 59, No. 1. pp. 91-98.
@article{465bc0f8012645298f807e4740db1355,
title = "Depentylation of [3H-pentyl]methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome P450 isoforms",
abstract = "Methyl-n-amylnitrosamine (MNAN) induces esophageal cancer in rats, probably involving activation by cytochromes P450. We studied the metabolic depentylation of MNAN. [3H-4,5-pentyl]-MNAN and [3H-2,3-pentyl]. MNAN were synthesized, purified, and incubated with rat esophageal microsomes (REM) or rat liver microsomes (RLM) to give [3H]pentaldehyde (depentylation), an indicator of MNAN activation. [3H]Pentaldehyde was determined by high- performance liquid chromatography of its 2,4-dinitrophenylhydrazone. Adding 5 mM semicarbazide to incubations increased the observed depentylation (except that due to CYP2E1) by >60{\%}. MNAN depentylation by REM and uninduced and induced RLM showed K(m) values of 64, 610, and 170-330 μM, respectively (V(max): 20, 220, and 160-1270 pmol/mg protein/min, respectively). The depentylation of 100 μM MNAN by REM was inhibited 98{\%} by CO and 65{\%} by coumarin preincubated for 15 min with REM (K(i), 120 μM) but was unaffected by antibodies inhibitory to various P450s. MNAN inhibited coumarin 7- hydroxylation by RLM and CYP2A6 (K(i), 3000 and 320 μM, respectively). REM showed slight coumarin 7-hydroxylase activity. MNAN depentylation by RLM was 41{\%} inhibited by an antibody to CYP2C11. K(m) for rat CYP2E1, human CYP2E1, and human CYP2A6 was 210, 115, and 17 μM, respectively (V(max:) 900, 570, and 120 pmol/nmol P450/min, respectively). We conclude that MNAN activation by REM is probably due to a P450 related to CYP2A3, a rodent nasal P450.",
author = "Chen, {Sheng C.} and Xiaojie Wang and Guoping Xu and Lin Zhou and Vennerstrom, {Jonathan L.} and Frank Gonzalez and Gelboin, {Harry V.} and Mirvish, {Sidney S.}",
year = "1999",
month = "1",
day = "1",
language = "English (US)",
volume = "59",
pages = "91--98",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Depentylation of [3H-pentyl]methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome P450 isoforms

AU - Chen, Sheng C.

AU - Wang, Xiaojie

AU - Xu, Guoping

AU - Zhou, Lin

AU - Vennerstrom, Jonathan L.

AU - Gonzalez, Frank

AU - Gelboin, Harry V.

AU - Mirvish, Sidney S.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Methyl-n-amylnitrosamine (MNAN) induces esophageal cancer in rats, probably involving activation by cytochromes P450. We studied the metabolic depentylation of MNAN. [3H-4,5-pentyl]-MNAN and [3H-2,3-pentyl]. MNAN were synthesized, purified, and incubated with rat esophageal microsomes (REM) or rat liver microsomes (RLM) to give [3H]pentaldehyde (depentylation), an indicator of MNAN activation. [3H]Pentaldehyde was determined by high- performance liquid chromatography of its 2,4-dinitrophenylhydrazone. Adding 5 mM semicarbazide to incubations increased the observed depentylation (except that due to CYP2E1) by >60%. MNAN depentylation by REM and uninduced and induced RLM showed K(m) values of 64, 610, and 170-330 μM, respectively (V(max): 20, 220, and 160-1270 pmol/mg protein/min, respectively). The depentylation of 100 μM MNAN by REM was inhibited 98% by CO and 65% by coumarin preincubated for 15 min with REM (K(i), 120 μM) but was unaffected by antibodies inhibitory to various P450s. MNAN inhibited coumarin 7- hydroxylation by RLM and CYP2A6 (K(i), 3000 and 320 μM, respectively). REM showed slight coumarin 7-hydroxylase activity. MNAN depentylation by RLM was 41% inhibited by an antibody to CYP2C11. K(m) for rat CYP2E1, human CYP2E1, and human CYP2A6 was 210, 115, and 17 μM, respectively (V(max:) 900, 570, and 120 pmol/nmol P450/min, respectively). We conclude that MNAN activation by REM is probably due to a P450 related to CYP2A3, a rodent nasal P450.

AB - Methyl-n-amylnitrosamine (MNAN) induces esophageal cancer in rats, probably involving activation by cytochromes P450. We studied the metabolic depentylation of MNAN. [3H-4,5-pentyl]-MNAN and [3H-2,3-pentyl]. MNAN were synthesized, purified, and incubated with rat esophageal microsomes (REM) or rat liver microsomes (RLM) to give [3H]pentaldehyde (depentylation), an indicator of MNAN activation. [3H]Pentaldehyde was determined by high- performance liquid chromatography of its 2,4-dinitrophenylhydrazone. Adding 5 mM semicarbazide to incubations increased the observed depentylation (except that due to CYP2E1) by >60%. MNAN depentylation by REM and uninduced and induced RLM showed K(m) values of 64, 610, and 170-330 μM, respectively (V(max): 20, 220, and 160-1270 pmol/mg protein/min, respectively). The depentylation of 100 μM MNAN by REM was inhibited 98% by CO and 65% by coumarin preincubated for 15 min with REM (K(i), 120 μM) but was unaffected by antibodies inhibitory to various P450s. MNAN inhibited coumarin 7- hydroxylation by RLM and CYP2A6 (K(i), 3000 and 320 μM, respectively). REM showed slight coumarin 7-hydroxylase activity. MNAN depentylation by RLM was 41% inhibited by an antibody to CYP2C11. K(m) for rat CYP2E1, human CYP2E1, and human CYP2A6 was 210, 115, and 17 μM, respectively (V(max:) 900, 570, and 120 pmol/nmol P450/min, respectively). We conclude that MNAN activation by REM is probably due to a P450 related to CYP2A3, a rodent nasal P450.

UR - http://www.scopus.com/inward/record.url?scp=0032589899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032589899&partnerID=8YFLogxK

M3 - Article

C2 - 9892192

AN - SCOPUS:0032589899

VL - 59

SP - 91

EP - 98

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 1

ER -